Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer. (Q38351611)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer. |
scientific article |
Statements
Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer (English)
John N Flanagan
Shasha Zheng
Kun-Chun Chiang
Atsushi Kittaka
Toshiyuki Sakaki
Sachie Nakabayashi
Xiansi Zhao
Remco A Spanjaard
Kelly S Persons
Jeffrey S Mathieu
Michael F Holick
1 September 2009